Alkermes plc. (ALKS) Financial Statements (2026 and earlier)

Company Profile

Business Address CONNAUGHT HOUSE
DUBLIN 4, 00000
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)
Annual | Quarterly

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments752773608536635535
Cash and cash equivalent291457292338273204
Short-term investments461316316199362331
Restricted cash and investments      
Receivables385332288313275257
Inventory, net of allowances, customer advances and progress billings183186181150126102
Inventory183186181150126102
Contract with customer, asset, after allowance for credit loss 51913148
Asset, held-for-sale, not part of disposal group  94    
Business combination, contingent consideration, asset    68 
Other undisclosed current assets919844435360
Total current assets:1,4151,4861,1301,0621,111962
Noncurrent Assets
Operating lease, right-of-use asset849111611613212
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization228227325341350362
Long-term investments and receivables73401322292579
Long-term investments73401322292579
Intangible asset, including goodwill, after accumulated amortization8485131167204244
Goodwill838393939393
Intangible asset, excluding goodwill, after accumulated amortization123874111151
Deferred income tax assets1551961168286 
Business combination, contingent consideration, asset    172532
Other noncurrent assets171215111717
Other undisclosed noncurrent assets      97
Total noncurrent assets:640651834962839843
TOTAL ASSETS:2,0562,1361,9642,0241,9501,805
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:185241220446412373
Employee-related liabilities✕✕✕✕7771 
Accounts payable466633564654
Accrued liabilities140175187767693
Other undisclosed accounts payable and accrued liabilities    237219226
Deferred revenue 137687
Debt  333311
Disposal group, including discontinued operation  5    
Other undisclosed current liabilities2792692681616 
Total current liabilities:465520498471438391
Noncurrent Liabilities
Long-term debt and lease obligation  288290397392280
Long-term debt, excluding current maturities  288290293272274
Liabilities, other than long-term debt125126132445349
Deferred revenue    111622
Other liabilities565042323727
Operating lease, liability6976901041195
Total noncurrent liabilities:125413422441444329
Total liabilities:591934920912883720
Equity
Equity, attributable to parent1,4651,2031,0441,1131,0671,085
Common stock222222
Treasury stock, value(419)(189)(161)(143)(126)(118)
Additional paid in capital2,8612,7372,9132,7982,6862,586
Accumulated other comprehensive loss(2)(3)(11)(4)(1)(2)
Accumulated deficit(976)(1,344)(1,699)(1,541)(1,493)(1,382)
Total equity:1,4651,2031,0441,1131,0671,085
TOTAL LIABILITIES AND EQUITY:2,0562,1361,9642,0241,9501,805

Income Statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues1,5581,6631,1121,1741,0391,171
Cost of revenue
(Cost of Product and Service Sold)		(245)(253)(218)(197)(178)(180)
Gross profit:1,3121,410894976860991
Operating expenses(892)(996)(1,036)(1,006)(973)(1,166)
Operating income (loss):421414(142)(29)(112)(175)
Nonoperating income (expense)237(25)(10)16(22)
Investment income, nonoperating423182714
Other nonoperating income (expense)3(0)20141
Interest and debt expense(23)(23)(13)(0)(9)(14)
Other undisclosed income from continuing operations before equity method investments, income taxes     914
Income (loss) from continuing operations before equity method investments, income taxes:421398(180)(39)(97)(197)
Other undisclosed income from continuing operations before income taxes2323130  
Income (loss) from continuing operations before income taxes:444422(167)(39)(97)(197)
Income tax expense (benefit)(72)989(9)(14)0
Income (loss) from continuing operations:372519(158)(48)(111)(197)
Loss before gain (loss) on sale of properties:✕✕✕✕(48)(111)(197)
Loss from discontinued operations (6)(165)    
Other undisclosed net income 11    
Net income (loss) available to common stockholders, diluted:367356(158)(48)(111)(197)

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):367356(158)(48)(111)(197)
Comprehensive income (loss):367356(158)(48)(111)(197)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent18(7)(2)01
Comprehensive income (loss), net of tax, attributable to parent:368364(165)(51)(110)(195)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: